Homology Medicines Inc
NASDAQ:QTTB
Homology Medicines Inc
NASDAQ:QTTB
Price:
5.85
USD
2.27%
Market Closed
Market Cap:
$85.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Homology Medicines Inc
NASDAQ:QTTB
|
US |
|
Lec Inc
TSE:7874
|
JP |
|
G
|
Glenveagh Properties PLC
ISEQ:GVR
|
IE |
|
V
|
Visa Steel Ltd
NSE:VISASTEEL
|
IN |
|
A
|
Advance United Holdings Inc
CNSX:AUHI
|
CA |
|
Haimo Technologies Group Corp
SZSE:300084
|
CN |
|
Nancal Technology Co Ltd
SSE:603859
|
CN |
|
I
|
Ion Exchange (India) Ltd
NSE:IONEXCHANG
|
IN |
|
Kimura Chemical Plants Co Ltd
TSE:6378
|
JP |
|
S
|
Sigachi Industries Ltd
NSE:SIGACHI
|
IN |
|
B
|
Business-intelligence of Oriental Nations Corp Ltd
SZSE:300166
|
CN |
|
DICK'S Sporting Goods Inc
NYSE:DKS
|
US |
|
Hyloris Pharmaceuticals SA
XBRU:HYL
|
BE |
Income Statement
Earnings Waterfall
Homology Medicines Inc
Homology Medicines Inc
Income Statement
Homology Medicines Inc
Homology Medicines Inc
Currency: USD
| Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Revenue |
0
N/A
|
1
N/A
|
3
+124%
|
4
+63%
|
5
+29%
|
4
-16%
|
3
-23%
|
2
-34%
|
2
-27%
|
2
+19%
|
2
+9%
|
2
+6%
|
3
+18%
|
31
+1 064%
|
33
+5%
|
34
+3%
|
34
-1%
|
5
-84%
|
4
-25%
|
3
-22%
|
3
+0%
|
3
0%
|
3
-14%
|
2
-29%
|
1
-41%
|
0
-70%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
54
N/A
|
|
| Operating Income | ||||||||||||||||||||||||||||||||||
| Operating Expenses |
(30)
|
(37)
|
(46)
|
(56)
|
(65)
|
(79)
|
(92)
|
(107)
|
(112)
|
(123)
|
(131)
|
(128)
|
(133)
|
(126)
|
(123)
|
(126)
|
(130)
|
(138)
|
(134)
|
(136)
|
(136)
|
(126)
|
(128)
|
(119)
|
(93)
|
(81)
|
(67)
|
(61)
|
(66)
|
(63)
|
(55)
|
(44)
|
(37)
|
|
| Selling, General & Administrative |
(8)
|
(10)
|
(13)
|
(15)
|
(17)
|
(18)
|
(19)
|
(22)
|
(22)
|
(25)
|
(28)
|
(31)
|
(33)
|
(33)
|
(34)
|
(34)
|
(37)
|
(42)
|
(41)
|
(41)
|
(38)
|
(32)
|
(32)
|
(32)
|
(31)
|
(28)
|
(24)
|
(22)
|
(18)
|
(18)
|
(18)
|
(17)
|
(18)
|
|
| Research & Development |
(21)
|
(27)
|
(33)
|
(41)
|
(48)
|
(61)
|
(73)
|
(85)
|
(89)
|
(98)
|
(103)
|
(98)
|
(100)
|
(93)
|
(89)
|
(93)
|
(93)
|
(96)
|
(93)
|
(95)
|
(98)
|
(94)
|
(96)
|
(88)
|
(62)
|
(52)
|
(42)
|
(39)
|
(48)
|
(45)
|
(37)
|
(26)
|
(19)
|
|
| Operating Income |
(30)
N/A
|
(36)
-20%
|
(43)
-21%
|
(52)
-21%
|
(60)
-15%
|
(74)
-24%
|
(89)
-20%
|
(105)
-18%
|
(110)
-5%
|
(121)
-10%
|
(129)
-6%
|
(126)
+2%
|
(130)
-3%
|
(95)
+27%
|
(90)
+5%
|
(92)
-3%
|
(96)
-4%
|
(132)
-38%
|
(130)
+2%
|
(132)
-2%
|
(133)
-1%
|
(123)
+8%
|
(126)
-2%
|
(117)
+7%
|
(92)
+21%
|
(80)
+13%
|
(67)
+16%
|
(61)
+9%
|
(66)
-8%
|
(63)
+4%
|
(55)
+14%
|
(44)
+21%
|
17
N/A
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||||
| Interest Income Expense |
1
|
1
|
2
|
3
|
4
|
5
|
6
|
6
|
6
|
6
|
5
|
3
|
2
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
3
|
5
|
6
|
6
|
6
|
0
|
5
|
6
|
5
|
6
|
3
|
2
|
1
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
131
|
131
|
131
|
131
|
0
|
0
|
(7)
|
(1)
|
0
|
0
|
5
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
12
|
|
| Total Other Income |
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
20
|
16
|
16
|
16
|
(0)
|
1
|
1
|
2
|
|
| Pre-Tax Income |
(30)
N/A
|
(35)
-16%
|
(41)
-19%
|
(49)
-19%
|
(56)
-14%
|
(69)
-25%
|
(83)
-20%
|
(99)
-19%
|
(104)
-5%
|
(115)
-11%
|
(124)
-8%
|
(123)
+1%
|
(129)
-5%
|
(94)
+27%
|
(90)
+5%
|
(92)
-3%
|
(96)
-4%
|
(1)
+99%
|
2
N/A
|
1
-60%
|
1
+82%
|
(119)
N/A
|
(120)
-1%
|
(118)
+2%
|
(87)
+26%
|
(60)
+31%
|
(46)
+23%
|
(34)
+26%
|
(46)
-35%
|
(58)
-27%
|
(52)
+10%
|
(42)
+20%
|
30
N/A
|
|
| Net Income | ||||||||||||||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
|
| Income from Continuing Operations |
(30)
|
(35)
|
(41)
|
(49)
|
(56)
|
(69)
|
(83)
|
(99)
|
(104)
|
(115)
|
(124)
|
(123)
|
(129)
|
(94)
|
(90)
|
(92)
|
(96)
|
(2)
|
1
|
(0)
|
0
|
(118)
|
(120)
|
(118)
|
(87)
|
(60)
|
(46)
|
(34)
|
(46)
|
(58)
|
(52)
|
(42)
|
30
|
|
| Equity Earnings Affiliates |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(2)
|
(4)
|
(5)
|
(8)
|
(12)
|
(13)
|
(26)
|
(23)
|
(19)
|
(16)
|
(2)
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
(30)
N/A
|
(35)
-16%
|
(41)
-19%
|
(49)
-19%
|
(56)
-14%
|
(69)
-25%
|
(83)
-20%
|
(99)
-19%
|
(104)
-5%
|
(115)
-11%
|
(124)
-8%
|
(123)
+1%
|
(129)
-5%
|
(94)
+27%
|
(90)
+5%
|
(92)
-3%
|
(96)
-4%
|
(3)
+97%
|
(1)
+55%
|
(4)
-267%
|
(5)
-17%
|
(126)
-2 414%
|
(132)
-5%
|
(131)
+1%
|
(113)
+14%
|
(83)
+26%
|
(65)
+22%
|
(50)
+24%
|
(48)
+4%
|
(60)
-25%
|
(52)
+13%
|
(42)
+20%
|
30
N/A
|
|
| EPS (Diluted) |
-0.89
N/A
|
-0.92
-3%
|
-1.11
-21%
|
-1.3
-17%
|
-1.95
-50%
|
-1.87
+4%
|
-1.92
-3%
|
-2.24
-17%
|
-2.47
-10%
|
-2.55
-3%
|
-2.75
-8%
|
-2.73
+1%
|
-2.8
-3%
|
-1.87
+33%
|
-1.58
+16%
|
-1.61
-2%
|
-1.73
-7%
|
-0.04
+98%
|
-0.02
+50%
|
-0.07
-250%
|
-0.09
-29%
|
-2.2
-2 344%
|
-2.3
-5%
|
-2.28
+1%
|
-35.16
-1 442%
|
-35.65
-1%
|
-5.43
+85%
|
-4.11
+24%
|
-5.12
-25%
|
-4.9
+4%
|
-4.3
+12%
|
-3.45
+20%
|
2.42
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
